Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome

被引:41
作者
Esel, D [1 ]
Doganay, M
Alp, E
Sumerkan, B
机构
[1] Erciyes Univ, Fac Med, Dept Microbiol, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Infect Dis, TR-38039 Kayseri, Turkey
关键词
blood culture; bloodstream infection; antimicrobial resistance;
D O I
10.1046/j.1469-0691.2003.00714.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aims of this prospective study were to: (1) determine the rate of blood culture contamination; (2) describe and compare the epidemiologic, clinical and microbiological characteristics of hospital- and community-acquired bloodstream infections; and (3) determine the mortality resulting from bloodstream infections. The rate of true bacteremia was 12.1%, and 10.7% of cultures were contaminated. Of the 567 episodes of bloodstream infection, 73.4% were hospital-acquired, and 26.6% were community-acquired. The most commonly isolated microorganisms were staphylococci (44%, methicillin resistant 69.4%), enterococci (15%) and Escherichia coli (12.5%) in hospital-acquired episodes, and Brucella spp. (21.9%), E. coli (19.2%) and Staphylococcus aureus (14.6%, methicillin resistant 9.1%) in community-acquired episodes. While the overall mortality rate was 25.4%, death attributable to bloodstream infections was 16.6% in hospital-acquired episodes and 13.9% in community-acquired episodes. The highest mortality occurred in patients with bacteremia due to Pseudomonas aeruginosa (37.5%) in hospital-acquired episodes, and in patients with bacteremia due to Streptococcus pneumoniae (50%) in community-acquired episodes. Underlying diseases, severity of illness, presence of bladder catheter, previous use of antibiotics, tracheal intubation and adequacy of treatment were found to be significantly associated with death.
引用
收藏
页码:1038 / 1044
页数:7
相关论文
共 23 条
[1]  
[Anonymous], M100S11 NCCLS
[2]   GRAM-POSITIVE ORGANISMS AND SEPSIS [J].
BONE, RC .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (01) :26-34
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]  
BOUZA E, 1999, CLIN MICROBIOL INFEC, V5, P1
[5]   The changing epidemiology of Staphylococcus aureus? [J].
Chambers, HF .
EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :178-182
[6]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[7]  
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[8]  
DUNNE WM, 1997, CUMULATIVE TECHNIQ B, V1, P1
[9]   Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].
Edmond, MB ;
Wallace, SE ;
McClish, DK ;
Pfaller, MA ;
Jones, RN ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244
[10]   THE CAUSATIVE ORGANISMS OF SEPTICEMIA AND THEIR EPIDEMIOLOGY [J].
EYKYN, SJ ;
GRANSDEN, WR ;
PHILLIPS, I .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :41-58